ReCET Study | Type 2 Diabetes | Clinical Trial
What is the ReCET Procedure? The ReCET Procedure is a non-surgical, investigational treatment designed to improve blood sugar control in adults with Type 2 Diabetes.
ReCET Treatment by Endogenex
The ReCET Study is a pivotal clinical study evaluating the use of the Endogenex System in people living with type 2 diabetes. The ReCET Study will be enrolling participants at clinical …
Researchers study novel endoscopic therapy for type 2 diabetes
Feb 24, 2024 · Endoscopic re-cellularization via electroporation therapy (ReCET), also known as endoscopic duodenal mucosal regeneration, is a novel endoscopic procedure and device …
Study Details | NCT06267391 - ClinicalTrials.gov
Feb 20, 2024 · A Multicenter, Randomized, Double-blind, Sham-controlled Study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals …
Diabetes Breakthrough: New Treatment Eliminates Insulin
Oct 17, 2024 · This innovative approach, which combines a novel procedure known as ReCET (Re-Cellularization via Electroporation Therapy) with semaglutide, resulted in the elimination of …
Recellularization via electroporation therapy of the duodenum …
Recellularization via electroporation therapy (ReCET) is a novel endoscopic procedure that uses electroporation to induce cellular apoptosis and subsequent reepithelization.
Endogenex offers ReCET system study results for type 2 diabetes
May 3, 2025 · Endogenex will present results today of a trial studying its ReCET pulsed electric field (PEF) system in type 2 diabetes patients, saying the investigational procedure …
852-P: Duodenal Recellularization via Electroporation Therapy (ReCET …
Jun 20, 2023 · Introduction: Re-Cellularization via Electroporation Therapy (ReCET™), a novel endoscopic procedure using electroporation to elicit apoptosis of the duodenal mucosa. In this …
Endoscopic Intestinal Re-Cellularization Therapy in Type II …
The ReCET device is designed to treat the lining of the first part of the small intestine (duodenum) in order to improve blood sugar control in individuals with T2D. The procedure is done through …
Endogenex designed the ReCET system to treat type 2 diabetes
Jun 20, 2025 · ReCET treats inflamed and dysfunctional tissue associated with type 2 diabetic duodenopathy, delivering nonthermal pulsed electric field (PEF) energy to mucosal and …